Skip to main content
. 2023 Sep 12;28(18):6586. doi: 10.3390/molecules28186586

Figure 5.

Figure 5

Three-dimensional binding interaction diagrams of 28, 30, and Erlotinib within the active site of BRAFV600E (BRAFm; PDB ID: 3OG7).